oligoprogressive

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC, Oligoprogressive, Small-cell Lung Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 27, 2023

Esophageal Cancer, Small Bowel Cancer, Gastroesophageal-junction Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Esophageal Cancer
  • +10 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 27, 2023

Breast Cancer, Oligoprogressive, Head Neck Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Breast Cancer
  • +4 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 19, 2023

Prostate Cancer, Oligoprogressive, Urothelial Carcinoma Trial in Sacramento (Ablative local therapy)

Recruiting
  • Prostate Cancer
  • +3 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 19, 2023

Oligoprogressive Trial (IMSA101, Immune checkpoint inhibitor, PULSAR)

Not yet recruiting
  • Oligoprogressive
  • (no location specified)
May 5, 2023

Breast Cancer Invasive, Metastatic Cancer, Oligoprogressive Trial in Amsterdam (procedure, radiation, other)

Not yet recruiting
  • Breast Cancer Invasive
  • +2 more
  • Surgery
  • +2 more
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek
Mar 21, 2022

Head Neck Cancer, Metastatic Cancer, Oligoprogressive Trial in Montréal (Standard arm, Experimental arm)

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Standard arm
  • Experimental arm
  • Montréal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal
Mar 6, 2022

NSCLC, Oligoprogressive Trial in Guangzhou (Furmonertinib)

Recruiting
  • Non-small Cell Lung Cancer
  • Oligoprogressive
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Jul 10, 2021

Oligoprogressive, Castration-Resistant Prostate Cancer Trial in Toronto (Stereotactic Body Radiation Therapy (SABR))

Recruiting
  • Oligoprogressive
  • Castration-Resistant Prostate Cancer
  • Stereotactic Body Radiation Therapy (SABR)
  • Toronto, Ontario, Canada
    Odette Cancer Centre
Apr 9, 2021